Delivery Order SPE2DB22D3501-SPE2DB24FVM34
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Entecavir 0.5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $6,506.04 and an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $20,215.18 for the supply of Entecavir 0.5 mg tablets. The award has an ultimate completion date of December 8, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $9,458.03 firm fixed-price delivery order is for the supply of 4,565,749,496 tablets of the medication Entecavir 0.5 mg. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,216.29 firm-fixed-price delivery order is for the supply of 4,557,972,328 units of the generic drug Entecavir 0.5 mg tablets. The award is not designated under a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,306,825 units of the drug Entecavir 0.5 mg tablets. The $7,376.51 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between the DLA Troop Support Medical and the parent company Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,341.22, is for the delivery of Entecavir 0.5 mg tablets. It is a firm fixed-price contract with a period of performance through May 21, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award for $1,361.61 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,269.85, is for the delivery of the prescription medication Entecavir 0.5 mg tablet. This is a firm fixed-price delivery order contract with an ultimate completion date of September 28, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.74, is for the delivery of 4564094934 Entecavir 0.5 mg Tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVM34Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $4,489.51 and has a completion date of May 1, 2024. The contract is for the delivery of 4,564,452,240 units of the pharmaceutical product Entecavir 0.5 mg Tablet 30s. This award is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate AmerisourceBergen's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/30/24 |